Skip to main content

$94.24 (0%)

High

$94.48

Low

$94.21

Trades

1,245

Turnover

$6,322,149

Volume

67,078
30 June 2023 at 4:13pm
Register to track BKL and receive email alerts.
Subject
stock_company_name Ann: 2021 Full Year Results Announcement

stock_company_name Ann: Dividend/Distribution - BKL

stock_company_name Ann: 2021 Annual Report

stock_company_name Ann: Appendix 4E

stock_company_name Ann: Final Director's Interest Notice - Christine Holman

stock_company_name Ann: Resignation of Director - Christine Holman

stock_company_name Ann: Application for quotation of securities - BKL

stock_company_name Ann: Company Secretary Appointment/Resignation

stock_company_name Ann: Change of Director's Interest Notice

stock_company_name Ann: Change of Director's Interest Notice

stock_company_name Ann: Macquarie Conference Presentation

stock_company_name Ann: Initial Director's Interest Notice

stock_company_name Ann: Initial Director's Interest Notice

stock_company_name Ann: BKL Non-Executive Director Appointments

stock_company_name Ann: BKL Shareholder Briefing

stock_company_name Ann: Appendix 2A

stock_company_name Ann: Appendix 2A

stock_company_name Ann: Update - Dividend/Distribution - BKL

stock_company_name Ann: Change in substantial holding

stock_company_name Ann: Change in substantial holding

stock_company_name Ann: BKL Half Year Investor Presentation

stock_company_name Ann: BKL Half Year Results Announcement

stock_company_name Ann: Dividend/Distribution - BKL

stock_company_name Ann: Half Year Accounts

stock_company_name Ann: Resignation of Joint Company Secretary

stock_company_name Ann: Becoming a substantial holder

stock_company_name Ann: Appendix 3G

stock_company_name Ann: Change of Director's Interest Notice

stock_company_name Ann: Completion of Global Therapeutics Divestment

stock_company_name Ann: Initial Director's Interest Notice

stock_company_name Ann: Final Director's Interest Notice

stock_company_name Ann: Final Director's Interest Notice

stock_company_name Ann: Results of Meeting

stock_company_name Ann: MCP: Global Therapeutics Acquisition & Equity Raise

stock_company_name Ann: Letter to Shareholders

stock_company_name Ann: Chairman's Address to Shareholders

stock_company_name Ann: Blackmores Announces Global Therapeutics Divestment

stock_company_name Ann: Blackmores Announces Board Renewal

stock_company_name Ann: Blackmores Group 2020 Sustainability Report

Register to track BKL and receive email alerts.

Similar Companies

AHY
BWX
BWX
BXN
EXL
FIJ
HCT
MCP
S66
SKN